To study the expression of Rho kinase (Rho associated coil forming protein kinase-1, ROCK-1) and its substrate myosin phosphatase target subunit 1 (myosin phosphatase target subunit-1, MYPT-1), connexin 40 (Cx40) and connexin 43 (Cx43) in the left atrial appendage of patients with atrial fibrillation, and explore the role of ROCK signaling pathway in patients with atrial fibrillation and its underlying mechanism.
INTRODUCTION
Atrial fibrillation (AF) is a common arrhythmia with high disability and mortality rate. The risk of cardiovascular diseases in patients with atrial fibrillation is significantly higher. As a member of the small G protein superfamily, Rho exerts GTPase activity. Rho/Rho kinase signal pathway is a common pathway in the human body. Rho kinase, also known as Rho associated coil forming protein kinase (ROCK), is the downstream effector molecule of Rho. Rho kinase comprises two subtypes: ROCK-1 and ROCK-2. There is a high expression of ROCK-1 in heart, lung, skeletal muscles, kidneys, and pancreas [Higashi 2003 ]. Myosine phosphatae targeting subunit 1 (MYPT-1) in myosin light chain phosphatase (MLCP) is the primary substrate of activated ROCK [Kimura 1996 ]. Rho kinase can inhibit MLCP by phosphorylation of MYPT-1 [Ito 2004 ]. Therefore, high phosphorylation level of MYPT-1 may reflect the activation of Rho/ROCK pathway. Many studies have shown that increased Rho kinase activity often leads to dysfunction of the cardiovascular system [Zhou 2011 ]. Connexin remodeling plays an important role in the incidence and development of atrial fibrillation [Pellman 2010 ]. Rho/Rho kinase signaling pathway is a hot topic in research concerning cardiovascular diseases; however, its relation to the pathogenesis of atrial fibrillation remains unknown.
In this study, the functional mechanism of Rho kinase was preliminarily explored through two steps: first, the expression level of ROCK-1 and the change of activated MYPT-1 were evaluated in tissue samples taken from AF and SR group, which could clarify the role of the Rho/Rock signal transduction pathway in the pathogenesis of AF. Second, the relationship between MYPT-1 and Cx proteins in the left atrial tissues in patients with AF were analyzed, and the mechanism underlying the activation of Rho kinase in AF was explored.
MATERIALS AND METHODS
An immunohistochemistry kit was purchased from Wuhan Boster Co. MYPT1, ROCK-1, Cx40 and Cx43 antibody, and GAPDH were all purchased from Santa Cruz (USA), and prestained protein molecular weight marker was purchased from Fermentas (Lithuania).
Patient Data
A total of 40 patients (12 males, 28 females) 20 to 68 years of age (mean age: 44) underwent thoracic surgery (mainly for rheumatic heart disease, congenital heart disease, atrial septal defect and ventricular septal defect and so on) in the Lanzhou military region general hospital during 2014. According to atrial fibrillation morbidity, the patients were divided into two groups: sinus rhythm group consisting of 20 cases and atrial fibrillation group consisting of 20 cases (6 paroxysmal atrial fibrillation and 14 persistent atrial fibrillation). Criteria for the diagnosis of atrial fibrillation was defined by the replacement of P wave by a series of tiny, differently shaped f waves of irregular frequency in an electrocardiogram test and the appearance of pulse deficit, arrhythmia, and cardiac tone of irregular force in the physical examination. Paroxysmal atrial fibrillation, which has a usual duration of less than 48 hours, can be spontaneously converted to sinus rhythm within seven days, while persistent atrial fibrillation often lasts for more than seven days and can be converted to sinus rhythm with medication. In addition to routine preoperative electrocardiogram and echocardiography, coronary arteriography should be employed for patient over 50 to rule out coronary heart disease. The preoperative heart function of all patients was classified as I-II according to the New York Heart Association (NYHA) functional classification system. There was no significant difference in sex composition ratio, age, and heart function between the two groups. Left atrial appendage tissue samples weighing about 100 mg each were cut from each patient's heart and immediately put on ice and stored at −80°C within 20 min of the cardiac operation. All tissue specimens were obtained with the approval of the ethics committee of the Lanzhou military region general hospital.
Immunohistochemistry
Expression of MYPT-1, ROCK-1, Cx40, and Cx43 in atrial tissue was detected by IHC. In brief, tissues in paraffin sections were treated with the following procedures: dewaxing, incubation with first and secondary antibody, DAB staining, and mounting with anti-fade oil. PBS was used as a negative control. Positive slides supported by Wuhan Boster (China) were taken as positive control. The dilution of primary antibody and secondary antibody were 1:50, 1:500 respectively. Cellular location analysis of ROCK-1 and MYPT-1 was observed under a microscope after immunohistochemical staining, and protein expression of Cx40 and Cx43 was calculated by Image-Pro Plus 6.0 software and presented as the mean optical density value. Differences and comparison of the two protein expressions in the left atrial appendage tissue were performed by GraphPad Prism (Version 6).
Western Blot
Expression of MYPT-1, ROCK-1, and Cx43 was analyzed by western blot. In brief, atrial muscle tissues were precooled in liquid nitrogen; then lysate buffer RIPA was added to it and grinded into homogenizing tissues. After centrifugation, the supernatant was collected and aliquoted. Using 100 μg protein and mixing with 5× protein loading buffer, the sample mixture was boiled for 5 min and centrifuged before loading. After adding protein marker, electrophoresis was performed under constant voltage of 80 V for 1.5 h to 2 h. Next, protein transfer to NC membrane was accomplished under constant voltage of 20V for 1.5 h. After separation from PAGE gel, NC membrane was blocked in 5% non-fat milk (dissolved in TBS-T) at room temperature for 1.5 h with slow shaking. The first antibody including MYPT-1, ROCK-1, and Cx43 was diluted by 5% milk/PBST at 1:300 ratio and incubated overnight at 4°C. After TBS-T washing three times, the secondary antibody of goat-anti-rabbit was diluted by 5% milk/ TBST at 1:2000 ratio and incubated at room temperature for 1 h. Again, the membrane was washed three times by TBS-T (15 min each time). The membrane was put in enhanced chemiluminescence (ECL) substrate for 2 min and the film was pressed and developed before detection of protein expression. Gray scale and area of the protein band were analyzed by a gel imaging system and protein expression level was indicated by the integral gray value (D, density). Figure 1 . The immunohistochemical staining results in different myocardial cells groups. A, upper panel, the expression of MYPT-1, ROCK-1, Cx40, Cx43 is present as brown-yellow spots in sinus myocardium cell respectively; lower panel, the expression of MYPT-1, ROCK-1, Cx40, Cx43 is shown as brown-yellow spots in cardiac myocytes, which also indicated that the above proteins are mainly distributed in cytoplasm. Scale bar = 50 μm. B, the quantification of the brown-yellow spots of different proteins using Imagepro-Plus. **P < .01, compared with sinus rhythm group.
Statistical Analysis
All statistical analyses were performed using the SPSS 17.0 statistical software package. The ANOVA test was employed to evaluate differences in the expression of protein between two categories of tissues. Pearson Spearman test was used to analyze the relationship between MYPT-1 and Cx40. P < .05 in all cases was considered statistically significant.
RESULTS

Expression of MYPT-, ROCK-1, Cx40 and Cx43 in Left Atrial Appendage
Cells positive for MYPT-1, ROCK-1, Cx40, and Cx43 were stained yellow or brown in the cytoplasm, and those unstained indicated the negative expression of the above markers. All of the MYPT-1, ROCK-1, Cx40, and Cx43 were mildly expressed in the left auricle (or left atrial appendage) of sinus rhythm (SR group), as observed under a microscope. A high expression of MYPT-1, ROCK-1, and Cx40 was observed in that of the atrial fibrillation group (AF group), while Cx43 was mildly expressed (Figure 1 ).
Protein Levels of ROCK-1, MYPT-1, Cx40 and Cx43 in Different Groups
As shown in Figure 2 , the expression of ROCK-1, MYPT-1, Cx40, and Cx43 was inconsistent with the immunochemistry results above; the expression of MYPT-1, ROCK-1, and Cx40 were significantly higher in the AF group than those of the SR group.
Correlation Analysis
As shown in Figure 3 , the expression of ROCK-1 protein showed positive correlation with the expression of MYPT-1 protein after the relative quantification of immunohistochemistry (r = 0.968, P < .05). (r = 0.983, P < .05). The expression of ROCK-1 protein was positively correlated with the expression of Cx40 protein (r = 0.963, P < .05).
DISCUSSION
Rho family is a kind of small G proteins with GTP enzyme activity, which in recent years was found to be widely expressed in all eukaryotic kingdoms. Their functions include molecular switch, swift between GTP-binding state (active) and GDP-binding state (inactive), triggering downstream kinase cascade reaction that results in various biological responses [Wettschureck 2002; Narumiya 1996 ]. There are three isoforms of Rho (A, B, and C) out of which Rho A is of paramount importance. Its downstream protein Rho kinase (ROCK) has been proven to play a pivotal role in cardiac functions. ROCK with molecular weight of 160kD belongs to threonine/serine protein kinase and comprises three domains; N-terminal kinase domain, coil domain with Rho binding site in the middle, and C-terminal cysteine-rich PH domain [Noma 2006; Loirand 2006 ]. ROCK1 and ROCK2 are highly homologous isoforms with 65% similarity in their amino acid sequences. Their similarity ratio can reach up to 92% in their kinase domain. ROCK1 is widely expressed in heart, lungs, skeletal muscles, kidneys, and pancreas [Higashi 2003 ].
Experimental studies have shown a close association between Rho/ROCK pathway and a variety of cardiovascular diseases. For example, data collected from experimental studies on both animal [Kandabashi 2000 ] and human models [Kandabashi 2002] show a significantly increased expression of ROCK mRNA expression in atherosclerotic lesions; rat models of experimental hypertension including both spontaneously hypertensive rats and chronic NO synthesis inhibition-induced hypertensive rats showed increased Rho/ROCK activity [Uehata 1997 ]. In a model of pulmonary hypertension induced by monocrotaline, ROCK inhibitor Fasudil improved pulmonary vascular remodeling and relieved the contraction of smooth muscle cells, thereby reducing pulmonary hypertension [Chapados 2006 ]. It also indirectly indicates the involvement of Rho/ROCK activation in the formation of pulmonary hypertension. Our results showed that there is a higher expression of ROCK-1 and MYPT-1 in auricula sinistra in the atrial fibrillation group than in the sinus rhythm group, which suggests that the activation of Rho/ROCK pathway is involved in the incidence of atrial fibrillation. It has been found that at least 25 different substrates of ROCK exist, most of which are involved in actin filament formation, and the organization and rearrangement of cytoskeleton [Shimokawa 2005 ]. Among them, myosin light chain phosphatase (MLCP) is the most studied protein [Mam 2010; Nossaman 2010] , which consists of one catalytic domain, a myosin light chain binding subunit (MYPT-1), and the noncatalytic structural subunit. ROCK can interact with the MYPT-1 of MLCP [Furuyama 2006 ]. Therefore, in this study, we first detected the expression of one subtype of Rhokinase, ROCK-1 and MYPT-1 in the left atrial appendage of atrial fibrillation patients, which may indicate the activation of Rho pathway.
Numerous studies have confirmed that ROCK is involved in oxidative stress, inflammation, fibrosis, apoptosis, ventricular remodeling and other biological processes by targeting its downstream molecules such as MYPT-1, cardiac troponin, PENT, MAPK, and their pathways. Atrial fibrosis and gap junction connexin (Cx) remodeling plays an essential role in AF progression [Pellman 2010; Severs 2004] , so an important question arises here: what does the Cx have to do with Rho kinase pathway? As an important component of the intercalated discs of myocardium, the gap junction (GJ) is the tunnel that transmits key electrical and chemical signals between myocardial cells, which in turn participates in the coordination of action potential and myocardial cell movement synchronization [Rackauskas 2010; Jansen 2010] . Connexin 40 and Connexin 43 are two important members of gap junction proteins in the human heart [Dupays 2003; Wang 2010] . Connexin 40 is mainly expressed in human atrial muscle, atrioventricular node, His bundle, left and right bundle branch, and proximal Purkinje fibers [Dupays 2003 ].
Mitogen-activated protein kinase (MAPK) is a serine/threonine protein kinase within the cells. In mammals there are three parallel MAPK pathways; extracellular signal-regulated kinase (ERK) pathway, c-jun N-terminal kinase (c-JNK) pathway, and p38 MAPK pathway. MAPK signaling networks are found in ventricular and atrial muscles of the heart. Evidence has shown that RhoA/ROCK pathway plays a regulatory role in these three MAPK signaling pathways [Wang 2010; Shatanawi 2011] . Studies have proven that the activation of ERK pathway (major and classical pathway in the MAPK pathway family) in cardiac cells results in various biological effects, such as proliferation of cardiac fibroblasts, increased matrix collagen and connexin remodeling through a series of complex signaling network. Therefore, our future study will focus on the expression of Cx40/Cx43 and their correlation with MYPT-1 in the left atrial appendage (LAA) of patients with atrial fibrillation (AF). Our previous studies suggested that the expression of Cx40 in the LAA of AF patients is significantly higher than those in the sinus rhythm group, which might be closely related to the imbalanced synthesis and degradation of connexin and the different sites of serine/threonine phosphorylation or dephosphorylation. However, in our study, the expression of Cx43 in LAA didn't show significant difference between AF patients and SR group. This is consistent with the study of Polontchouket al, who observed that Cx40 is 2.7 times more highly expressed in LAA of AF patients than in SR group, while Cx43 is expressed in the same degree in both AF patients and SR group.
Our results show that patients with atrial fibrillation show significantly higher expression of MYPT-1 and Cx40 in the left atrial appendage tissue than those in the sinus rhythm group, suggesting that activation of Rho/ROCK pathway is involved in the occurrence of atrial fibrillation. We also found expression of Cx40 MYPT-1 positively correlated in the AF group. In summary, our study indicates that Rho/ROCK may activate MYPT-1, thus upregulating the expression of Cx40, which in turn participates in the mechanism that leads to atrial fibrillation, a detailed molecular mechanism that needs to be further studied.
